Bright Minds Biosciences Inc.
DRUG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827401
No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Bright Minds Biosciences Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 14 | 9 | −5 |
| Shares | 412.9K | 418.4K | +5.52K (+1.3%) |
| Value | $509.0K | $309.6K | −$199.4K (−39.2%) |
New holders (2)
Institutions that held Bright Minds Biosciences Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 38,715 | $29.0K | 0.00% |
| StoneX Group Inc. | 10,193 | $7.54K | 0.00% |
Sold out (7)
Institutions that held Bright Minds Biosciences Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jane Street Group, LLC | 19,327 | $24.0K |
| Two Sigma Investments, LP | 11,069 | $14.0K |
| First Republic Investment Management, Inc. | 11,329 | $14.0K |
| Bank of America Corp | 10,655 | $13.0K |
| Two Sigma Securities, LLC | 10,204 | $13.0K |
| Tower Research Capital LLC (TRC) | 629 | $1.00K |
| Advisor Group Holdings, Inc. | 400 | $0 |